Arkolith/Insider Trading/CTSO/Form 4

Bloch Kathleen P.

Chief Financial OfficerCytosorbents Corp (CTSO) · full profile →Form 4 · filed Dec 15, 2023
Net Buying
Open-Market Buys
$50K
Open-Market Sells
$0
Net Open-Market Flow
$50K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 13, 2023Buy(P)38K$1.33$50K468K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 13, 2023Buy(P)13K——13K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-126427) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML